| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $66.9M | +12.6% |
| Cost of Revenue | $39.4M | +16.9% |
| Gross Profit | $27.5M | +7.0% |
| R&D Expense | $3.4M | +2.7% |
| SG&A Expense | $27.6M | +20.4% |
| Operating Income | -$5.3M | -248.6% |
| Pre-tax Income | -$7.5M | -24.6% |
| Income Tax | $202K | -48.7% |
| Net Income | -$7.2M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | -26.9% |
| Accounts Receivable | $5.4M | -41.4% |
| Inventory | $7.0M | -20.0% |
| Current Assets | $26.7M | -8.9% |
| Total Assets | $44.1M | -9.0% |
| Current Liabilities | $18.6M | -32.0% |
| Long-term Debt | $18.0M | -26.3% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -76.9% |
| Capital Expenditures | $1.3M | -53.0% |
| Investing Cash Flow | -$1.3M | +77.7% |
| Financing Cash Flow | $4.4M | +116.0% |
| Free Cash Flow | -$5.2M | -5.1% |
| +21.4% |
| Total Liabilities |
| $39.2M |
| -2.4% |
| Stockholders' Equity | $4.7M | -38.7% |